National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings, 27713-27714 [2017-12483]
Download as PDF
sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 82, No. 115 / Friday, June 16, 2017 / Notices
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Syed M Quadri, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6210,
MSC 7804, Bethesda, MD 20892, 301–435–
1211, quadris@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Computational, Modeling, and
Biodata Management.
Date: July 12, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington Embassy Row,
2015 Massachusetts Ave., NW., Washington,
DC 20036.
Contact Person: Allen Richon, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6184,
MSC 7892, Bethesda, MD 20892, 301–379–
9351, allen.richon@nih.hhs.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Drugs, Alcohol and Heavy Metals.
Date: July 12–13, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Michael Selmanoff, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5164,
MSC 7844, Bethesda, MD 20892, 301–435–
1119, selmanom@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Computational, Modeling, and
Biodata Management.
Date: July 12, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington Embassy Row,
2015 Massachusetts Ave., NW., Washington,
DC 20036.
Contact Person: Ross D Shonat, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6172,
MSC 7892, Bethesda, MD 20892, 301–435–
2786, ross.shonat@nih.hhs.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: June 12, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
[FR Doc. 2017–12482 Filed 6–15–17; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
17:12 Jun 15, 2017
Jkt 241001
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel NIAID; Investigator Initiated
Program Project Application (P01).
Date: July 13, 2017.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Paul A. Amstad, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room 3G41, NIAID/NIH/DHHS, 5601 Fishers
Lane, Bethesda, MD 20892–7616, 240–669–
5067, pamstad@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: June 12, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–12480 Filed 6–15–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health
and Health Disparities; Notice of
Closed Meeting
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
27713
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; Limited
Competition: NIMHD Endowment Program
for Increasing Research and Institutional
Resources—(S21).
Date: July 17, 2017.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Gateway Plaza, 533J, 7201 Wisconsin
Avenue, Suite 533, Bethesda, MD 20814.
Contact Person: Deborah Ismond, Ph.D.,
Scientific Review Officer, Division of
Scientific Programs, National Institute on
Minority Health and Health Disparities,
National Institutes of Health, 7201 Wisconsin
Ave., Suite 525, Bethesda, MD 20814, (301)
594–2704, ismonddr@mail.nih.gov.
Dated: June 12, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–12481 Filed 6–15–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group; Neurological Sciences and
Disorders A.
Date: June 26–27, 2017.
Time: 8:00 a.m. to 6:00 p.m.
E:\FR\FM\16JNN1.SGM
16JNN1
sradovich on DSK3GMQ082PROD with NOTICES
27714
Federal Register / Vol. 82, No. 115 / Friday, June 16, 2017 / Notices
Agenda: To review and evaluate grant
applications.
Place: Wyndham Grand Chicago River, 71
East Wacker Drive, Chicago, IL 60601.
Contact Person: Natalia Strunnikova,
Ph.D., Scientific Review Officer, Scientific
Review Branch, NINDS/NIH/DHHS,
Neuroscience Center, 6001 Executive Blvd.,
Suite 3204, MSC 9529, Bethesda, MD 20892–
9529, (301) 402–0288, Natalia.strunnikova@
nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; BRAIN U19 Review
Meeting.
Date: July 6–7, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: St. Gregory Hotel, 2033 M Street
NW., Washington, DC 20036.
Contact Person: Natalia Strunnikova,
Ph.D., Scientific Review Officer, Scientific
Review Branch, NINDS/NIH/DHHS,
Neuroscience Center, 6001 Executive Blvd.,
Suite 3204, MSC 9529, Bethesda, MD 20892–
9529, (301) 402–0288, Natalia.strunnikova@
nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; F32 and K22 Review.
Date: July 6–7, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Lorien Hotel and Spa, 1600 King
Street, Alexandria, VA 22314.
Contact Person: Jimok Kim, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529, (301)
496–9223, Jimok.kim@nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; R35 Review.
Date: July 10, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree by Hilton Washington
DC—Crystal City, 300 Army Navy Drive,
Arlington, VA 22202.
Contact Person: Birgit Neuhuber, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529,
neuhuber@ninds.nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; NSD Member Conflict.
Date: July 12, 2017.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
17:12 Jun 15, 2017
Jkt 241001
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Birgit Neuhuber, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529,
neuhuber@ninds.nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Clinical Trial Readiness for
Rare Neurological and Neuromuscular
Diseases.
Date: July 14, 2017.
Time: 8:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Lorien Hotel and Spa, 1600 King
Street, Alexandria, VA 22314.
Contact Person: Ana Olariu, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529, (301)
496–9223, ana.olariu@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: June 12, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–12483 Filed 6–15–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Project: Project—Division of State
Programs—Management Reporting
Tool (DSP–MRT) (OMB No. 0930–
0354)—Revision
The Substance Abuse and Mental
Health Services Administration
(SAMHSA)’s Center for Substance
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Abuse Prevention (CSAP) aims to
address two of SAMHSA’s top
substance abuse prevention priorities:
Underage drinking (UAD; age 12 to 20)
and prescription drug misuse and abuse
(PDM; age 12 to 25) through the
Division of State Program—Monitoring
and Reporting Tool. This data collection
will allow all DSP programs to report
into a standard tool that aligns with the
Strategic Prevention Framework model.
This request for data collection includes
a revision from a previously approved
OMB instrument formally known as
Partnerships for Success-Management
and Reporting Tool.
Monitoring data on SPF model will
allow SAMHSA project officers to
systematically collect data to monitor
their grant program performance and
outcomes along with grantee technical
assistance needs. In addition to
assessing activities related to the SPF
steps, the performance monitoring
instruments covered in this statement
collect data to assess the following
grantee required specific performance
measures:
• Number of training and technical
assistance activities per funded
community provided by the grantee to
support communities;
• Reach of training and technical
assistance activities (numbers served)
provided by the grantee;
• Percentage of subrecipient
communities that submit data to the
grantee data system;
• Number of sub-recipient
communities that improved on one or
more targeted NOMs indicators
(Outcome);
• Number of grantees who integrate
Prescription Drug Monitoring Data into
their program needs assessment.
Changes to this package include the
following:
• Standard language for all DSP–MRT
questions;
• New disparities module to align
with SAMHSA’s monitoring
requirements;
• Updated technical assistance
section;
• Deletion of cost questions specific
to funding amounts and in-kind
resources;
• Deletion of advisory council and
other workgroup sub-committee
questions;
• Addition of Section A specific to
SPF-Rx questions;
• Addition of Section B specific to
PDO questions;
E:\FR\FM\16JNN1.SGM
16JNN1
Agencies
[Federal Register Volume 82, Number 115 (Friday, June 16, 2017)]
[Notices]
[Pages 27713-27714]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-12483]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Neurological Disorders
and Stroke Initial Review Group; Neurological Sciences and Disorders
A.
Date: June 26-27, 2017.
Time: 8:00 a.m. to 6:00 p.m.
[[Page 27714]]
Agenda: To review and evaluate grant applications.
Place: Wyndham Grand Chicago River, 71 East Wacker Drive,
Chicago, IL 60601.
Contact Person: Natalia Strunnikova, Ph.D., Scientific Review
Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD
20892-9529, (301) 402-0288, Natalia.strunnikova@nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; BRAIN U19 Review Meeting.
Date: July 6-7, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: St. Gregory Hotel, 2033 M Street NW., Washington, DC
20036.
Contact Person: Natalia Strunnikova, Ph.D., Scientific Review
Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD
20892-9529, (301) 402-0288, Natalia.strunnikova@nih.gov.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; F32 and K22 Review.
Date: July 6-7, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Lorien Hotel and Spa, 1600 King Street, Alexandria, VA
22314.
Contact Person: Jimok Kim, Ph.D., Scientific Review Officer,
Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001
Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 20892-9529,
(301) 496-9223, Jimok.kim@nih.gov.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; R35 Review.
Date: July 10, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree by Hilton Washington DC--Crystal City, 300
Army Navy Drive, Arlington, VA 22202.
Contact Person: Birgit Neuhuber, Ph.D., Scientific Review
Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD
20892-9529, neuhuber@ninds.nih.gov.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; NSD Member Conflict.
Date: July 12, 2017.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Birgit Neuhuber, Ph.D., Scientific Review
Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD
20892-9529, neuhuber@ninds.nih.gov.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; Clinical Trial Readiness for Rare
Neurological and Neuromuscular Diseases.
Date: July 14, 2017.
Time: 8:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Lorien Hotel and Spa, 1600 King Street, Alexandria, VA
22314.
Contact Person: Ana Olariu, Ph.D., Scientific Review Officer,
Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001
Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 20892-9529,
(301) 496-9223, ana.olariu@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: June 12, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-12483 Filed 6-15-17; 8:45 am]
BILLING CODE 4140-01-P